NFKB1 and glioblastoma: Type I IFN-signaling pathway was analyzed by determining the activation of STAT1/2, IRF3 and NFκB p65 in GBM cells cultured with FBS- or hPL-supplemented medium for 6 h, 24 h, and 48 h.